NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

Search Plan my trip
NASDAQ / LIVE COMPANY INTELLIGENCE

BridgeBio Oncology Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERBBOT
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE COVERAGE

The company wire is refreshing.

No verified current item is available. Search remains available while sources reconnect.

Search BBOT →
PRIMARY DOCUMENTS / SEC EDGAR

Latest BBOT filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-08-11 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-05-12 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-03-05 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-09-08 · Period 2026-09-08SEC ↗8-KMaterial company eventFiled 2026-08-11 · Period 2026-08-11SEC ↗8-KMaterial company eventFiled 2026-06-22 · Period 2026-06-16SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-28 · Period 2026-06-16SEC ↗4Official SEC filingFiled 2026-09-14 · Period 2026-09-10SEC ↗
EARNINGS / QUARTERLY TRACKER

BridgeBio Oncology Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.